Information Provided By: 
Fly News Breaks for April 24, 2018
FMS
Apr 24, 2018 | 06:58 EDT
Deutsche Bank analyst Gunnar Romer upgraded Fresenius Medical Care to Buy from Hold and raised his price target for the shares to EUR 102 from EUR 83. The stock is down 10% since end of January, mainly due to lackluster guidance communication and concerns around potential reimbursement pressure in the U.S., Romer tells investors in a research note. However, Fresenius Medical's underlying earnings momentum "remains healthy" and potential reimbursement pressure appears manageable, the analyst contends.
News For FMS From the Last 2 Days
There are no results for your query FMS
